0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Point-of-Care (POC) Infectious Disease Diagnostics/Testing Market Size, Status and Forecast 2020-2026
Published Date: March 2020
|
Report Code: QYRE-Auto-2G2078
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Point of Care Infectious Disease Diagnostics Testing Market Size Status and Forecast 2020 2026

Global Point-of-Care (POC) Infectious Disease Diagnostics/Testing Market Size, Status and Forecast 2020-2026

Code: QYRE-Auto-2G2078
Report
March 2020
125 Pages
QYResearch
Region: Global, North America, Japan, Europe, Central & South America, Southeast Asia,
Description
Table of Content
Tables & Figures

Market Analysis and Insights: Point-of-Care (POC) Infectious Disease Diagnostics/Testing Market

In 2019, the global Point-of-Care Infectious Disease Diagnostics/Testing market size was USD 997.7 million and it is expected to reach USD 1452 million by the end of 2026, with a CAGR of 5.4% during 2021-2026.

Point-of-Care (POC) Infectious Disease Diagnostics/Testing Scope and Market Size

Point-of-Care Infectious Disease Diagnostics/Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point-of-Care Infectious Disease Diagnostics/Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Point-of-Care Infectious Disease Diagnostics/Testing market is segmented into HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, Other Infectious Disease POC, etc.

Segment by Application, the Point-of-Care Infectious Disease Diagnostics/Testing market is segmented into Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others, etc.

Point-of-Care (POC) Infectious Disease Diagnostics/Testing Market Regional and Country-level Analysis

The Point-of-Care (POC) Infectious Disease Diagnostics/Testing market is analysed and market size information is provided by regions (countries).

The key regions covered in the Point-of-Care Infectious Disease Diagnostics/Testing market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape and Point-of-Care (POC) Infectious Disease Diagnostics/Testing Market Share Analysis

Point-of-Care Infectious Disease Diagnostics/Testing market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Point-of-Care Infectious Disease Diagnostics/Testing business, the date to enter into the Point-of-Care Infectious Disease Diagnostics/Testing market, Point-of-Care Infectious Disease Diagnostics/Testing product introduction, recent developments, etc.

The major vendors include Abbott, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health, Quest Diagnostics Inc., Bio-Rad Labs Inc., bioMérieux SA, Sight Diagnostics Ltd., Gene POC, Trivitron Healthcare, OJ-Bio Ltd., Ortho-Clinical Diagnostics, etc.

This report focuses on the global Point-of-Care Infectious Disease Diagnostics/Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Point-of-Care Infectious Disease Diagnostics/Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

  • Abbott
  • Thermo Fisher Scientific Inc
  • Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • BD & Company
  • Chembio Diagnostics Inc.
  • Trinity Biotech
  • Cardinal Health
  • Quest Diagnostics Inc.
  • Bio-Rad Labs Inc.
  • bioMérieux SA
  • Sight Diagnostics Ltd.
  • Gene POC
  • Trivitron Healthcare
  • OJ-Bio Ltd.
  • Ortho-Clinical Diagnostics

Point-of-Care (POC) Infectious Disease Diagnostics/Testing Market segment by Type, the product can be split into

  • HIV POC
  • Clostridium difficile POC
  • HBV POC
  • Pneumonia or Streptococcus associated infections
  • Respiratory syncytial virus (RSV) POC
  • HPV POC
  • Influenza/Flu POC
  • Other Infectious Disease POC

Point-of-Care (POC) Infectious Disease Diagnostics/Testing Market segment by Application, split into

  • Hospitals
  • Clinics
  • Home
  • Assisted Living Healthcare Facilities
  • Laboratories
  • Others

Point-of-Care (POC) Infectious Disease Diagnostics/Testing Market segment by Regions/Countries, this report covers

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics/Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 HIV POC
1.4.3 Clostridium difficile POC
1.4.4 HBV POC
1.4.5 Pneumonia or Streptococcus associated infections
1.4.6 Respiratory syncytial virus (RSV) POC
1.4.7 HPV POC
1.4.8 Influenza/Flu POC
1.4.9 Other Infectious Disease POC
1.5 Market by Application
1.5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home
1.5.5 Assisted Living Healthcare Facilities
1.5.6 Laboratories
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Perspective (2015-2026)
2.2 Point-of-Care Infectious Disease Diagnostics/Testing Growth Trends by Regions
2.2.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Share by Regions (2015-2020)
2.2.3 Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Point-of-Care Infectious Disease Diagnostics/Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Point-of-Care Infectious Disease Diagnostics/Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Market Size
3.1.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Revenue (2015-2020)
3.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio
3.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Point-of-Care Infectious Disease Diagnostics/Testing Revenue in 2019
3.3 Point-of-Care Infectious Disease Diagnostics/Testing Key Players Head office and Area Served
3.4 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product Solution and Service
3.5 Date of Enter into Point-of-Care Infectious Disease Diagnostics/Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Size by Type (2015-2020)
4.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Type (2021-2026)
5 Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Application (2015-2026)
5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
5.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
6.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in North America (2019-2020)
6.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
6.4 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
7.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Europe (2019-2020)
7.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
7.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
8 China
8.1 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
8.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in China (2019-2020)
8.3 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
8.4 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
9.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Japan (2019-2020)
9.3 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
9.4 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
10.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
11 India
11.1 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
11.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in India (2019-2020)
11.3 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
11.4 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2020)
12.2 Point-of-Care Infectious Disease Diagnostics/Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
12.4 Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Point-of-Care Infectious Disease Diagnostics/Testing Introduction
13.1.4 Abbott Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Thermo Fisher Scientific Inc
13.2.1 Thermo Fisher Scientific Inc Company Details
13.2.2 Thermo Fisher Scientific Inc Business Overview and Its Total Revenue
13.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Introduction
13.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
13.2.5 Thermo Fisher Scientific Inc Recent Development
13.3 F. Hoffmann-La Roche Ltd
13.3.1 F. Hoffmann-La Roche Ltd Company Details
13.3.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
13.3.3 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Introduction
13.3.4 F. Hoffmann-La Roche Ltd Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Ltd Recent Development
13.4 Siemens Healthineers
13.4.1 Siemens Healthineers Company Details
13.4.2 Siemens Healthineers Business Overview and Its Total Revenue
13.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Introduction
13.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
13.4.5 Siemens Healthineers Recent Development
13.5 BD & Company
13.5.1 BD & Company Company Details
13.5.2 BD & Company Business Overview and Its Total Revenue
13.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Introduction
13.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
13.5.5 BD & Company Recent Development
13.6 Chembio Diagnostics Inc.
13.6.1 Chembio Diagnostics Inc. Company Details
13.6.2 Chembio Diagnostics Inc. Business Overview and Its Total Revenue
13.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
13.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
13.6.5 Chembio Diagnostics Inc. Recent Development
13.7 Trinity Biotech
13.7.1 Trinity Biotech Company Details
13.7.2 Trinity Biotech Business Overview and Its Total Revenue
13.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Introduction
13.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
13.7.5 Trinity Biotech Recent Development
13.8 Cardinal Health
13.8.1 Cardinal Health Company Details
13.8.2 Cardinal Health Business Overview and Its Total Revenue
13.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Introduction
13.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
13.8.5 Cardinal Health Recent Development
13.9 Quest Diagnostics Inc.
13.9.1 Quest Diagnostics Inc. Company Details
13.9.2 Quest Diagnostics Inc. Business Overview and Its Total Revenue
13.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
13.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
13.9.5 Quest Diagnostics Inc. Recent Development
13.10 Bio-Rad Labs Inc.
13.10.1 Bio-Rad Labs Inc. Company Details
13.10.2 Bio-Rad Labs Inc. Business Overview and Its Total Revenue
13.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
13.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
13.10.5 Bio-Rad Labs Inc. Recent Development
13.11 bioMérieux SA
10.11.1 bioMérieux SA Company Details
10.11.2 bioMérieux SA Business Overview and Its Total Revenue
10.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.11.4 bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.11.5 bioMérieux SA Recent Development
13.12 Sight Diagnostics Ltd.
10.12.1 Sight Diagnostics Ltd. Company Details
10.12.2 Sight Diagnostics Ltd. Business Overview and Its Total Revenue
10.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.12.4 Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.12.5 Sight Diagnostics Ltd. Recent Development
13.13 Gene POC
10.13.1 Gene POC Company Details
10.13.2 Gene POC Business Overview and Its Total Revenue
10.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.13.4 Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.13.5 Gene POC Recent Development
13.14 Trivitron Healthcare
10.14.1 Trivitron Healthcare Company Details
10.14.2 Trivitron Healthcare Business Overview and Its Total Revenue
10.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.14.4 Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.14.5 Trivitron Healthcare Recent Development
13.15 OJ-Bio Ltd.
10.15.1 OJ-Bio Ltd. Company Details
10.15.2 OJ-Bio Ltd. Business Overview and Its Total Revenue
10.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.15.4 OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.15.5 OJ-Bio Ltd. Recent Development
13.16 Ortho-Clinical Diagnostics
10.16.1 Ortho-Clinical Diagnostics Company Details
10.16.2 Ortho-Clinical Diagnostics Business Overview and Its Total Revenue
10.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.16.4 Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.16.5 Ortho-Clinical Diagnostics Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
 
    Table 1. Point-of-Care Infectious Disease Diagnostics/Testing Key Market Segments
    Table 2. Key Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics/Testing Revenue
    Table 3. Ranking of Global Top Point-of-Care Infectious Disease Diagnostics/Testing Manufacturers by Revenue (US$ Million) in 2019
    Table 4. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 5. Key Players of HIV POC
    Table 6. Key Players of Clostridium difficile POC
    Table 7. Key Players of HBV POC
    Table 8. Key Players of Pneumonia or Streptococcus associated infections
    Table 9. Key Players of Respiratory syncytial virus (RSV) POC
    Table 10. Key Players of HPV POC
    Table 11. Key Players of Influenza/Flu POC
    Table 12. Key Players of Other Infectious Disease POC
    Table 13. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 14. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions (US$ Million): 2020 VS 2026
    Table 15. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions (2015-2020) (US$ Million)
    Table 16. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2015-2020)
    Table 17. Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 18. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2021-2026)
    Table 19. Market Top Trends
    Table 20. Key Drivers: Impact Analysis
    Table 21. Key Challenges
    Table 22. Point-of-Care Infectious Disease Diagnostics/Testing Market Growth Strategy
    Table 23. Main Points Interviewed from Key Point-of-Care Infectious Disease Diagnostics/Testing Players
    Table 24. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Players (2015-2020) (Million US$)
    Table 25. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Players (2015-2020)
    Table 26. Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Infectious Disease Diagnostics/Testing as of 2019)
    Table 27. Global Point-of-Care Infectious Disease Diagnostics/Testing by Players Market Concentration Ratio (CR5 and HHI)
    Table 28. Key Players Headquarters and Area Served
    Table 29. Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product Solution and Service
    Table 30. Date of Enter into Point-of-Care Infectious Disease Diagnostics/Testing Market
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
    Table 33. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Type (2015-2020)
    Table 34. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Type (2021-2026)
    Table 35. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Application (2015-2020)
    Table 36. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
    Table 37. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Application (2021-2026)
    Table 38. North America Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
    Table 39. North America Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
    Table 40. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
    Table 41. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
    Table 42. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
    Table 43. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
    Table 44. Europe Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
    Table 45. Europe Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
    Table 46. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
    Table 47. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
    Table 48. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
    Table 49. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
    Table 50. China Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
    Table 51. China Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
    Table 52. China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
    Table 53. China Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
    Table 54. China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
    Table 55. China Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
    Table 56. Japan Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
    Table 57. Japan Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
    Table 58. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
    Table 59. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
    Table 60. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
    Table 61. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
    Table 62. Southeast Asia Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
    Table 63. Southeast Asia Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
    Table 64. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
    Table 65. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
    Table 66. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
    Table 67. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
    Table 68. India Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
    Table 69. India Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
    Table 70. India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
    Table 71. India Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
    Table 72. India Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
    Table 73. India Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
    Table 74. Central & South America Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (2019-2020) (Million US$)
    Table 75. Central & South America Key Players Point-of-Care Infectious Disease Diagnostics/Testing Market Share (2019-2020)
    Table 76. Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (Million US$)
    Table 77. Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
    Table 78. Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (Million US$)
    Table 79. Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
    Table 80. Abbott Company Details
    Table 81. Abbott Business Overview
    Table 82. Abbott Product
    Table 83. Abbott Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 84. Abbott Recent Development
    Table 85. Thermo Fisher Scientific Inc Company Details
    Table 86. Thermo Fisher Scientific Inc Business Overview
    Table 87. Thermo Fisher Scientific Inc Product
    Table 88. Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 89. Thermo Fisher Scientific Inc Recent Development
    Table 90. F. Hoffmann-La Roche Ltd Company Details
    Table 91. F. Hoffmann-La Roche Ltd Business Overview
    Table 92. F. Hoffmann-La Roche Ltd Product
    Table 93. F. Hoffmann-La Roche Ltd Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 94. F. Hoffmann-La Roche Ltd Recent Development
    Table 95. Siemens Healthineers Company Details
    Table 96. Siemens Healthineers Business Overview
    Table 97. Siemens Healthineers Product
    Table 98. Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 99. Siemens Healthineers Recent Development
    Table 100. BD & Company Company Details
    Table 101. BD & Company Business Overview
    Table 102. BD & Company Product
    Table 103. BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 104. BD & Company Recent Development
    Table 105. Chembio Diagnostics Inc. Company Details
    Table 106. Chembio Diagnostics Inc. Business Overview
    Table 107. Chembio Diagnostics Inc. Product
    Table 108. Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 109. Chembio Diagnostics Inc. Recent Development
    Table 110. Trinity Biotech Company Details
    Table 111. Trinity Biotech Business Overview
    Table 112. Trinity Biotech Product
    Table 113. Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 114. Trinity Biotech Recent Development
    Table 115. Cardinal Health Business Overview
    Table 116. Cardinal Health Product
    Table 117. Cardinal Health Company Details
    Table 118. Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 119. Cardinal Health Recent Development
    Table 120. Quest Diagnostics Inc. Company Details
    Table 121. Quest Diagnostics Inc. Business Overview
    Table 122. Quest Diagnostics Inc. Product
    Table 123. Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 124. Quest Diagnostics Inc. Recent Development
    Table 125. Bio-Rad Labs Inc. Company Details
    Table 126. Bio-Rad Labs Inc. Business Overview
    Table 127. Bio-Rad Labs Inc. Product
    Table 128. Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 129. Bio-Rad Labs Inc. Recent Development
    Table 130. bioMérieux SA Company Details
    Table 131. bioMérieux SA Business Overview
    Table 132. bioMérieux SA Product
    Table 133. bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 134. bioMérieux SA Recent Development
    Table 135. Sight Diagnostics Ltd. Company Details
    Table 136. Sight Diagnostics Ltd. Business Overview
    Table 137. Sight Diagnostics Ltd. Product
    Table 138. Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 139. Sight Diagnostics Ltd. Recent Development
    Table 140. Gene POC Company Details
    Table 141. Gene POC Business Overview
    Table 142. Gene POC Product
    Table 143. Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 144. Gene POC Recent Development
    Table 145. Trivitron Healthcare Company Details
    Table 146. Trivitron Healthcare Business Overview
    Table 147. Trivitron Healthcare Product
    Table 148. Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 149. Trivitron Healthcare Recent Development
    Table 150. OJ-Bio Ltd. Company Details
    Table 151. OJ-Bio Ltd. Business Overview
    Table 152. OJ-Bio Ltd. Product
    Table 153. OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 154. OJ-Bio Ltd. Recent Development
    Table 155. Ortho-Clinical Diagnostics Company Details
    Table 156. Ortho-Clinical Diagnostics Business Overview
    Table 157. Ortho-Clinical Diagnostics Product
    Table 158. Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (Million US$)
    Table 159. Ortho-Clinical Diagnostics Recent Development
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type: 2020 VS 2026
    Figure 2. HIV POC Features
    Figure 3. Clostridium difficile POC Features
    Figure 4. HBV POC Features
    Figure 5. Pneumonia or Streptococcus associated infections Features
    Figure 6. Respiratory syncytial virus (RSV) POC Features
    Figure 7. HPV POC Features
    Figure 8. Influenza/Flu POC Features
    Figure 9. Other Infectious Disease POC Features
    Figure 10. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application: 2020 VS 2026
    Figure 11. Hospitals Case Studies
    Figure 12. Clinics Case Studies
    Figure 13. Home Case Studies
    Figure 14. Assisted Living Healthcare Facilities Case Studies
    Figure 15. Laboratories Case Studies
    Figure 16. Others Case Studies
    Figure 17. Point-of-Care Infectious Disease Diagnostics/Testing Report Years Considered
    Figure 18. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth 2015-2026 (US$ Million)
    Figure 19. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions: 2020 VS 2026
    Figure 20. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2021-2026)
    Figure 21. Porter's Five Forces Analysis
    Figure 22. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Players in 2019
    Figure 23. Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Infectious Disease Diagnostics/Testing as of 2019
    Figure 24. The Top 10 and 5 Players Market Share by Point-of-Care Infectious Disease Diagnostics/Testing Revenue in 2019
    Figure 25. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 26. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 27. China Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 28. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 29. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 30. India Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 31. Central & South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2020) (Million US$)
    Figure 32. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 33. Abbott Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 34. Thermo Fisher Scientific Inc Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 35. Thermo Fisher Scientific Inc Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 36. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 37. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 38. Siemens Healthineers Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 39. Siemens Healthineers Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 40. BD & Company Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 41. BD & Company Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 42. Chembio Diagnostics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 43. Chembio Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 44. Trinity Biotech Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 45. Trinity Biotech Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 46. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 47. Cardinal Health Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 48. Quest Diagnostics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 49. Quest Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 50. Bio-Rad Labs Inc. Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 51. Bio-Rad Labs Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 52. bioMérieux SA Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 53. bioMérieux SA Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 54. Sight Diagnostics Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 55. Sight Diagnostics Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 56. Gene POC Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 57. Gene POC Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 58. Trivitron Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 59. Trivitron Healthcare Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 60. OJ-Bio Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 61. OJ-Bio Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 62. Ortho-Clinical Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 63. Ortho-Clinical Diagnostics Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Global and China Mycobacterium Tuberculosis Antibodies Market Insights Forecast to 2027
Global and China Mycobacterium Tuberculosis Antibodies Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-15D7777
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Escherichia Coli Antibody Market Insights Forecast to 2027
Global and China Escherichia Coli Antibody Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-20G7629
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and United States Chlamydia Trachomatis Antibodies Market Insights Forecast to 2027
Global and United States Chlamydia Trachomatis Antibodies Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-21F7760
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Prophylactic HIV Drug Market Insights Forecast to 2027
Global and China Prophylactic HIV Drug Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-7T7637
Sun Nov 21 00:00:00 UTC 2021

Add to Cart